Advertisement
UK markets close in 2 hours 16 minutes

  • FTSE 100

    8,332.16
    +18.49 (+0.22%)
     

  • FTSE 250

    20,379.19
    -33.89 (-0.17%)
     

  • AIM

    777.25
    +0.83 (+0.11%)
     

  • GBP/EUR

    1.1608
    -0.0016 (-0.14%)
     

  • GBP/USD

    1.2480
    -0.0030 (-0.24%)
     

  • Bitcoin GBP

    49,609.12
    -1,338.96 (-2.63%)
     

  • CMC Crypto 200

    1,320.35
    +25.68 (+1.98%)
     

  • DOW

    38,884.26
    +31.99 (+0.08%)
     

  • CRUDE OIL

    77.72
    -0.66 (-0.84%)
     

  • GOLD FUTURES

    2,323.80
    -0.40 (-0.02%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     

  • DAX

    18,436.76
    +6.71 (+0.04%)
     

  • CAC 40

    8,122.90
    +47.22 (+0.58%)
     
Money:

How to make a tax-free income

Tips for making money that won't be taxed

Smith & Nephew buoyed by sports medicine but China weak

Reuters - UK Focus

LONDON, July 28 (Reuters) - Smith & Nephew (LSE: SN.L - news) , Europe's biggest maker of artificial knees and hips, reported a 2 percent rise in second-quarter revenue on Thursday, helped by good growth in its sports medicine joint repair business.

But demand for its products in China and the Gulf States remained weak.

Revenue of $1.19 billion, which was broadly in line with analyst expectations, generated trading profit down 3 percent at $483 million. (Reporting by Ben Hirschler; editing by Susan Thomas)